Table 1

Demographic and clinical characteristics of the study population

10/20 mg RSV10/20 mg ATVPlacebo/20 mg RSV
n13611963
Age (years)58.6 ± 9.358.2 ± 9.758.5 ± 9.0
Male sex87 (64.0)78 (65.5)43 (68.3)
Caucasian race134 (98.5)116 (97.5)60 (95.2)
BMI (kg/m2)30.5 ± 3.831.0 ± 3.530.4 ± 4.0
Metabolic syndrome criteria
    Abdominal obesity*123 (90.4)116 (97.5)57 (90.5)
    Triglycerides ≥1.70 mmol/l (150 mg/dl)110 (80.9)81 (68.1)52 (82.5)
    Low HDL cholesterol73 (53.7)54 (45.4)24 (38.1)
    Blood pressure ≥130/85 mmHg128 (94.1)113 (95.0)60 (95.2)
    Fasting glucose 6.11–6.94 mmol/l33 (24.3)29 (24.4)14 (22.2)
  • Data are means ± SD orn(%).

  • *Waist circumference >102 cm for men and >88 cm for women.

  • †HDL cholesterol <1.04 mmol/l (40 mg/dl) for men and <1.30 mmol/l (50 mg/dl) for women.